| 1 |
Li X，Song P，Li J，et al.The disease burden and clinical characteristics of inflammatory bowel disease in the Chinese population：A systematic review and meta-analysis[J]．Int J Environ Res Public Health，2017，14(3)：238.
|
| 2 |
Panara AJ，Yarur AJ，Rieders B，et al.The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease：a cohort study[J]．Aliment Pharmacol Ther，2014，39(8)：802-810.
|
| 3 |
Nowakowski J，Chrobak AA，Dudek D．Psychiatric illnesses in inflammatory bowel diseases-psychiatric comorbidity and biological underpinnings[J]．Psychiatr Pol，2016，50(6)：1157-1166.
|
| 4 |
Torres J，Ellul P，Langhorst J，et al.European Crohn′s and colitis organisation topical review on complementary medicine and psychotherapy in inflammatory bowel disease[J]．J Crohns Colitis，2019，13(6)：673-685e.
|
| 5 |
McMahon AW，Schmitt P，Patterson JF，et al.Personality differences between inflammatory bowel disease patients and their healthy siblings[J]．Psychosom Med，1973，35(2)：91-103.
|
| 6 |
Regueiro M，Greer JB，Szigethy E．Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases[J]．Gastroenterology，2017，152(2)：430-439.e4.
|
| 7 |
SAVAGE N．Q&A：EVA SZIGETHY[J]．Nature，2016，540：S113.
|
| 8 |
Kochar B，Barnes EL，Long MD，et al.Depression is Associated with more aggressive inflammatory bowel disease[J]．Am J Gastroenterol，2018，113(1)：80-85.
|
| 9 |
Choi K，Chun J，Han K，et al.Risk of anxiety and depression in patients with inflammatory bowel disease：a nationwide，population-based study[J]．J Clin Med，2019，8(5)：654.
|
| 10 |
Stapersma L，van den Brink G，Szigethy EM，et al.Systematic review with meta-analysis：anxiety and depression in children and adolescents with inflammatory bowel disease[J]．Aliment Pharmacol Ther，2018，48(5)：496-506.
|
| 11 |
Costello EJ，Copeland W，Angold A．Trends in psychopathology across the adolescent years：what changes when children become adolescents，and when adolescents become adults？[J]．J Child Psychol Psychiatry，2011，52(10)：1015-1025.
|
| 12 |
Ananthakrishnan AN，Khalili H，Pan A，et al.Association between depressive symptoms and incidence of Crohn′s disease and ulcerative colitis：results from the nurses′health study[J]．Clin Gastroenterol Hepatol，2013，11(1)：57-62.
|
| 13 |
Bernstein CN，Zhang L，Lix LM，et al.The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease[J]．Inflamm Bowel Dis，2018，24(9)：1867-1875.
|
| 14 |
Narula N，Pinto-Sanchez MI，Calo NC，et al.Anxiety but not depression predicts poor outcomes in inflammatory bowel disease[J]．Inflamm Bowel Dis.2019，25(7)：1255-1261.
|
| 15 |
Walker JR，Ediger JP，Graff LA，et al.The Manitoba IBD cohort study：a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders[J]．Am J Gastroenterol，2008，103(8)：1989-1997.
|
| 16 |
Persoons P，Vermeire S，Demyttenaere K，et al.The impact of major depressive disorder on the short-and long-term outcome of Crohn′s disease treatment with infliximab[J]．Aliment Pharmacol Ther，2005，22(2)：101-110.
|
| 17 |
Frolkis AD，Vallerand IA，Shaheen AA，et al.Depression increases the risk of inflammatory bowel disease，which may be mitigated by the use of antidepressants in the treatment of depression[J]．Gut，2019，68(9)：1606-1612.
|
| 18 |
FilipovićBR，FilipovićBF，Kerkez M，et al.Depression and anxiety levels in therapy-naive patients with inflammatory bowel disease and cancer of the colon[J]．World J Gastroenterol.2007，13(3)：438-443.
|
| 19 |
Barberio B，Zamani M，Black CJ，et al.Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease：a systematic review and meta-analysis[J]．Lancet Gastroenterol Hepatol，2021，6(5)：359-370.
|
| 20 |
Narula N，Pinto-Sanchez MI，Calo NC，et al.Anxiety but not depression predicts poor outcomes in inflammatory bowel disease[J]．Inflamm Bowel Dis，2019，25(7)：1255-1261.
|
| 21 |
GRACIE DJ，GUTHRIE EA，HAMLIN PJ，et al.Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease[J]．Gastroenterology，2018，154(6)：1635-1646.
|
| 22 |
Yongwen Ng J，Chauhan U，Armstrong D，et al.A comparison of the prevalence of anxiety and depression between uncomplicated and complex IBD patient groups[J]．Gastroenterol Nurs，2018，41(5)：427-435.
|
| 23 |
Häuser W，Janke KH，Klump B，et al.Anxiety and depression in patients with inflammatory bowel disease：comparisons with chronic liver disease patients and the general population[J]．Inflamm Bowel Dis，2011，17(2)：621-632.
|
| 24 |
Mikocka-Walus A，Pittet V，Rossel JB，et al.Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease[J]．Clin Gastroenterol Hepatol，2016，14(6)：829-835.e1.
|
| 25 |
Michielan A，D′Inca R．Intestinal Permeability in Inflammatory Bowel Disease：Pathogenesis，Clinical Evaluation，and Therapy of Leaky Gut[J]．Mediators Inflamm，2015，2015：628157.
|
| 26 |
Barbara G，Barbaro MR，Fuschi D，et al.Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier[J]．Front Nutr，2021，8：718356.
|
| 27 |
Lakatos P L，Kiss L S，Palatka K，et al.Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn′s disease[J]．Inflamm Bowel Dis，2011，17(3)：767-777.
|
| 28 |
Grigoleit JS，Kullmann JS，Wolf OT，et al.Dose-dependent effects of endotoxin on neurobehavioral functions in humans[J]．PLoS One，2011，6(12)：e28330.
|
| 29 |
Brzozowski B，Mazur-Bialy A，Pajdo R，et al.Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease(IBD)：Role of Brain-Gut Axis[J]．Curr Neuropharmacol，2016，14(8)：892-900.
|
| 30 |
Stevens B R，Goel R，Seungbum K，et al.Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression[J]．Gut，2018，67(8)：1555-1557.
|
| 31 |
Moulton C D，Pavlidis P，Norton C，et al.Depressive symptoms in inflammatory bowel disease：an extraintestinal manifestation of inflammation？[J]．Clin Exp Immunol，2019，197(3)：308-318.
|
| 32 |
Liskiewicz P，Kaczmarczyk M，Misiak B，et al.Analysis of gut microbiota and intestinal integrity markers of inpatients with major depressive disorder[J]．Prog Neuropsychopharmacol Biol Psychiatry，2021，106：110076.
|
| 33 |
Ali GC，Ryan G，De Silva MJ.Validated screening tools for common mental disorders in low and middle income countries：a systematic review[J]．PLoS One，2016，11(6)：e0156939.
|
| 34 |
Guyatt G，Mitchell A，Irvine EJ，et al.A new measure of health status for clinical trials in inflammatory bowel disease[J]．Gastroenterology，1989，96(3)：804-810.
|
| 35 |
Cohen S，Kamarck T，Mermelstein R．A global measure of perceived stress[J]．J Health Soc Behav，1983，24(4)，385-396.
|
| 36 |
Zigmond AS，Snaith RP.The hospital anxiety and depression scale[J]．Acta Psychiatr Scand，1983，67(6)：361-370.
|
| 37 |
Brenner EJ，Long MD，Mann CM，et al.Responsiveness of the patient-reported outcomes measurement information system(PROMIS)pediatric measures to changes in disease status and quality of life among children and adolescents with crohn′s disease[J]．Inflamm Bowel Dis.2021，27(3)：344-351.
|
| 38 |
Purvis TE，Neuman BJ，Riley LH，et al.Comparison of PROMIS anxiety and depression，PHQ-8，and GAD-7 to screen for anxiety and depression among patients presenting for spine surgery[J]．J Neurosurg Spine，2019，18：1-8.
|
| 39 |
Zimmerman M，Martinez JH，Young D，et al.Severity classification on the Hamilton Depression Rating Scale[J]．J Affect Disord，2013，150(2)：384-388.
|
| 40 |
Hu S，Chen Y，Chen Y，et al.Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease[J]．Front Psychiatry.2021，12：714057.
|
| 41 |
Hanwella R，Ekanayake S，de Silva VA.The validity and reliability of the sinhala translation of the patient health questionnaire(PHQ-9)and PHQ-2 screener[J]．Depress Res Treat，2014，2014：768978.
|
| 42 |
Marc LG，Henderson WR，Desrosiers A，et al.Reliability and validity of the Haitian Creole PHQ-9.J Gen Intern Med，2014，29(12)：1679-1686.
|
| 43 |
Zachar-Tirado CN，Donders J．Clinical utility of the GAD-7 in identifying anxiety disorders after traumatic brain injury[J]．Brain Inj，2021，35(6)：655-660.
|
| 44 |
Plummer F，Manea L，Trepel D，et al.Screening for anxiety disorders with the GAD-7 and GAD-2：a systematic review and diagnostic metaanalysis[J]．Gen Hosp Psychiatry，2016，39：24-31.
|
| 45 |
Kroenke K，Spitzer RL，Williams JB，et al.Anxiety disorders in primary care：prevalence，impairment，comorbidity，and detection[J]．Ann Intern Med，2007，146(5)：317-325.
|
| 46 |
Swinson RP.The GAD-7 scale was accurate for diagnosing generalised anxiety disorder[J]．Evid Based Med，2006，11(6)：184.
|
| 47 |
Norman SB，Cissell SH，Means-Christensen AJ，et al.Development and validation of an overall anxiety severity and impairment scale(OASIS)[J]．Depress Anxiety，2006，23(4)：245-249.
|
| 48 |
Bernstein CN，Zhang L，Lix LM，et al.The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease[J]．Inflamm Bowel Dis，2018，24(9)：1867-1875.
|
| 49 |
美国精神医学学会．张道龙，刘春宇，张小梅等，译．精神障碍诊断与统计手册[M].5版．北京：北京大学出版社，2015：149-176.
|
| 50 |
Gracie DJ，Irvine AJ，Sood R，et al.Effect of psychological therapy on disease activity，psychological comorbidity，and quality of life in inflammatory bowel disease：a systematic review and meta-analysis[J]．Lancet Gastroenterol Hepatol，2017，2(3)：189-199.
|
| 51 |
Li C，Hou Z，Liu Y，et al.Cognitive-behavioural therapy in patients with inflammatory bowel diseases：A systematic review and meta-analysis[J]．Int J Nurs Pract，2019，25(1)：e12699.
|
| 52 |
Moser G．The role of hypnotherapy for the treatment of inflammatory bowel diseases[J]．Expert Rev Gastroenterol Hepatol，2014，8(6)：601-606.
|
| 53 |
Neilson K，Ftanou M，Monshat K，et al.A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease[J]．Inflamm Bowel Dis，2016，22(3)：694-701.
|
| 54 |
Fujitsuka N，Asakawa A，Hayashi M，et al.Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin[J]．Biol Psychiatry，2009，65(9)：748-759.
|
| 55 |
Papakostas GI，Stahl SM，Krishen A，et al.Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety(anxious depression)：a pooled analysis of 10 studies[J]．J Clin Psychiatry，2008，69(8)：1287-1292.
|
| 56 |
Frolkis AD，Vallerand IA，Shaheen AA，et al.Depression increases the risk of inflammatory bowel disease，which may be mitigated by the use of antidepressants in the treatment of depression[J]．Gut，2019，68(9)：1606-1612.
|
| 57 |
Thase ME.Are SNRIs more effective than SSRIs? A review of the current state of the controversy[J]．Psychopharmacol Bull，2008，41(2)：58–85.
|
| 58 |
Mikocka-Walus A，Hughes PA，Bampton P，et al.Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn′s Disease：a Pilot Randomized Placebo-Controlled Trial[J]．J Crohns Colitis，2017，11(4)：509-514.
|
| 59 |
Goodhand JR，Greig FI，Koodun Y，et al.Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study[J]．Inflamm Bowel Dis，2012，18(7)：1232-1239.
|
| 60 |
Iskandar HN，Cassell B，Kanuri N，et al.Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease[J]．J Clin Gastroenterol，2014，48(5)：423-429.
|
| 61 |
Jefferson JW，Rush AJ，Nelson JC，et al.Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy，pleasure，and interest：Findings from a randomized，double-blind，placebo-controlled study[J]．J Clin Psychiatry，2006，67(6)：865-873.
|
| 62 |
Hashash JG，Knisely MR，Germain A，et al.Brief Behavioral Therapy and Bupropion for Sleep and Fatigue in Young Adults With Crohn′s Disease：An Exploratory Open Trial Study[J]．Clin Gastroenterol Hepatol，2022，20(1)：96-104.
|